Conclusion: early recognition of uveitis in JIA is required to improve outcome,the reasons for our lower complication rates and better visual outcome may be the more frequent use of systemic immunosuppressive agents (particularly methotrexate and anti- TNF agents), and close collaboration between our pediatric ophthalmologists and pediatric rheumatologists. This evidence concerns the gene TNF and juvenile idiopathic arthritis.